Etiology, Diagnosis, Clinic and Treatment of Cutaneous Leishmaniasis

Authors

  • Sultanov Akram Abdukholikovich Tashkent Medical Academy, Termiz branch, assistant
  • Khaitov Kakhramon Najmitdinovich Tashkent Institute of Pediatric Medicine
  • Togaev Akhror Turakulovich Tashkent Medical Academy Termiz branch, assistant
  • Abdullaev Farrukh Abdullaevich Tashkent Medical Academy Termiz branch, assistant

Keywords:

cutaneous leishmaniasis, sodium stibogluconate, paromomycin, azoles

Abstract

Cutaneous leishmaniasis can present with localized, chronic, recurrent, diffuse, and sharp forms. For diagnostics, dermatoscopy, microscopy of biopsy material, smears - prints, skin scrapings; inoculation on NNN medium, PCR, serological diagnostics. 4 types of histological manifestations of infection are characteristic: I - abundant amastigotes, II - macrophages, polymorphonuclear neutrophils, plasma cells, necrosis, III – early granuloma with focal accumulation of epithelial cells, lymphocytes and a small number of plasma cells, IV - well-formed epithelioid granuloma in the dermis with Langerhans giant cells, lymphocytes and epithelioid cells. First line drugs for cutaneous leishmaniasis are preparations of pentavalent antimony: sodium stibogluconate intravenously or intramuscularly, meglumine antimonate intravenously or intramuscularly, miltefosine orally

Downloads

Published

2022-09-06

Issue

Section

Articles

How to Cite

Etiology, Diagnosis, Clinic and Treatment of Cutaneous Leishmaniasis. (2022). Eurasian Medical Research Periodical, 12, 14-18. https://geniusjournals.org/index.php/emrp/article/view/2116